Exagen Inc (NAS:XGN)
$ 2.75 -0.04 (-1.43%) Market Cap: 47.81 Mil Enterprise Value: 47.91 Mil PE Ratio: 0 PB Ratio: 2.72 GF Score: 70/100

Q2 2022 Exagen Inc Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT
Release Date Price: $8.3 (+4.27%)
Operator

Good day, ladies and gentlemen, and welcome to the Exagen Inc. Q2 2022 Earnings Call. (Operator Instructions).

At this time, it is my pleasure to turn the floor over to your host, Ryan Douglas, Investor Relations. Sir, the floor is yours.

Ryan Douglas
Exagen Inc. - Investors Relations Officer

Good afternoon, and thank you for joining us today. Earlier today, Exagen Inc. released financial results for the quarter ended June 30, 2022. The release is currently available on the company's website at www.exagen.com. Ron Rocca, President and Chief Executive Officer; Kamal Adawi, Chief Financial Officer; Mark Hazeltine, Chief Operating Officer, will host this afternoon's call.

Before we get started, I'd like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot